Sacituzumab govitecan

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T77824-5mg	5 mg				7 - 10 business days*		1,360.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2,... more

Close menu

Product information "Sacituzumab govitecan"

Description: Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2, facilitates the delivery of SN-38. It demonstrates anticancer activity [1]. Target: Antibody-Drug Conjugates (ADCs), Others. Smiles: C([C@@H]([C@@H]([C@@H](COP(OP(OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=3C(N=C2)=C(N)N=CN3)(=O)O)(=O)O)O)O)O)N4C=5C(=NC=6C4=CC(C)=C(C)C6)C(=O)NC(=O)N5

Keywords:	IMMU-132
Supplier:	TargetMol
Supplier-Nr:	T77824

Properties

Application:	Targets DNA topoisomerase I [EC:5.6.2.1] (TOP1)
Conjugate:	No
MW:	160 kD

Database Information

CAS :	1491917-83-9\| Matching products
KEGG ID :	K03163 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Sacituzumab govitecan"

Write a review